Preemptive Antiviral Agents in Kidney Transplant Recipients with Hepatitis B Virus Infection Reduced the Risk of Hepatitis B Virus Reactivation

被引:0
|
作者
Kim, J. M. [1 ]
Moon, H. H. [1 ]
Lee, S. [1 ]
Kim, T. -S. [1 ]
Song, S. [1 ]
Shin, M. [1 ]
Kwon, C. H. D. [1 ]
Kim, S. J. [1 ]
Joh, J. -W. [1 ]
Lee, S. -K. [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea
关键词
D O I
10.1097/00007890-201211271-01682
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
692
引用
收藏
页码:855 / 855
页数:1
相关论文
共 50 条
  • [1] Hepatitis B virus reactivation in kidney transplant patients with resolved hepatitis B virus infection: Risk factors and the safety and efficacy of preemptive therapy
    Mei, Takanori
    Noguchi, Hiroshi
    Hisadome, Yu
    Kaku, Keizo
    Nishiki, Takehiro
    Okabe, Yasuhiro
    Nakamura, Masafumi
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (02)
  • [2] Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection
    Tsai, Hsin-Ju
    Wu, Ming-Ju
    Chen, Cheng-Hsu
    Yang, Sheng-Shun
    Huang, Yi-Hsiang
    Chang, Yan-Zin
    Chang, Horng-Rong
    Lee, Teng-Yu
    [J]. TRANSPLANT INTERNATIONAL, 2023, 36
  • [3] HEPATITIS B VIRUS REACTIVATION IN KIDNEY TRANSPLANT RECIPIENTS TREATED WITH BELATACEPT
    Schwarz, Chloe
    Morel, Antoine
    Matignon, Marie
    Grimbert, Philippe
    Rondeau, Eric
    Ouali, Nacera
    Francois, Helene
    Mesnard, Laurent
    Petit-Hoang, Camille
    Rafat, Cedric
    Dahan, Karine
    Luque, Yosu
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I79 - I79
  • [4] Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept
    Schwarz, Chloe
    Morel, Antoine
    Matignon, Marie
    Grimbert, Philippe
    Rondeau, Eric
    Ouali, Nacera
    Francois, Helene
    Mesnard, Laurent
    Petit-Hoang, Camille
    Rafat, Cedric
    Dahan, Karine
    Luque, Yosu
    [J]. KIDNEY INTERNATIONAL REPORTS, 2023, 8 (08): : 1531 - 1541
  • [5] Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection
    Brar, T.
    Grewal, K.
    Vo, A.
    Driver, A.
    Wright, A.
    Partovi, N.
    Levy, R.
    Nador, R.
    Bergeron, C.
    Kapasi, A.
    Wilson, J.
    Samuels, J.
    Wright, R.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S461 - S461
  • [6] Prevalence of occult hepatitis B virus infection in kidney transplant recipients
    Franz, Cibele
    Perez, Renata de Mello
    Zalis, Mariano Gustavo
    Jonard Zalona, Ana Carolina
    de Castro e Abreu Rocha, Pedro Tulio Monteiro
    Goncalves, Renato Torres
    Nabuco, Leticia Cancella
    Villela-Nogueira, Cristiane Alves
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2013, 108 (05): : 657 - 660
  • [7] REACTIVATION OF HEPATITIS B VIRUS IN KIDNEY TRANSPLANT RECIPIENTS WITH RESOLVED INFECTION: A SINGLE-CENTER EXPERIENCE
    Pimenta, Goncalo
    Weigert, Andre
    Conde, Sara Querido
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I967 - I968
  • [8] Hepatitis B virus infection: resistance to antiviral agents
    Mutimer, D
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2001, 21 (03) : 239 - 242
  • [9] Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area
    Ko, WJ
    Chou, NK
    Hsu, RB
    Chen, YS
    Wang, SS
    Chu, SH
    Lai, MY
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (08): : 865 - 875
  • [10] Chronic hepatitis B virus infection in renal transplant recipients
    Kletzmayr, J
    Watschinger, B
    [J]. SEMINARS IN NEPHROLOGY, 2002, 22 (04) : 375 - 389